Dropping slow process in early clinical trials would make medicines available sooner

  • regul@lemm.ee
    link
    fedilink
    arrow-up
    2
    ·
    1 year ago

    Wouldn’t Japan have decades of data to analyze, though? Comparison of the global vs Japanese trials, any detected differences once released, etc. It’s not like they’re making this decision blind.